Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results?

Lignende værker

• Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer
  af: Kemeny, Nancy E., et al.
  Udgivet: (2011)
• Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response
  af: Yopp, Adam C., et al.
  Udgivet: (2011)
• Unresectable Intrahepatic Cholangiocarcinoma: Systemic Plus Hepatic Arterial Infusion Chemotherapy is Associated with Longer Survival Compared to Systemic Chemotherapy Alone
  af: Konstantinidis, Ioannis T., et al.
  Udgivet: (2015)
• Addition of Adjuvant Hepatic Artery Infusion to Systemic Chemotherapy Following Resection of Colorectal Liver Metastases Is Associated with Reduced Liver-Related Mortality
  af: Srouji, Rami, et al.
  Udgivet: (2020)
• Positive Postoperative CEA is a Strong Predictor of Recurrence for Patients After Resection for Colorectal Liver Metastases
  af: Araujo, Raphael L. C., et al.
  Udgivet: (2015)